Distinct and complementary functions of rho kinase isoforms ROCK1 and ROCK2 in prefrontal cortex structural plasticity
- 486 Downloads
Rho-associated protein kinases (ROCK) 1 and 2 are attractive drug targets for a range of neurologic disorders; however, a critical barrier to ROCK-based therapeutics is ambiguity over whether there are isoform-specific roles for ROCKs in neuronal structural plasticity. Here, we used a genetics approach to address this long-standing question by analyzing both male and female adult ROCK1+/− and ROCK2+/− mice compared to littermate controls. Individual pyramidal neurons in the medial prefrontal cortex (mPFC) were targeted for iontophoretic microinjection of fluorescent dye, followed by high-resolution confocal microscopy and neuronal 3D reconstructions for morphometry analysis. Increased apical and basal dendritic length and intersections were observed in ROCK1+/− but not ROCK2+/− mice. Although dendritic spine densities were comparable among genotypes, apical spine length was decreased in ROCK1+/− but increased in ROCK2+/− mice. Spine head and neck diameter were reduced similarly in ROCK1+/− and ROCK2+/− mice; however, certain spine morphologic subclasses were more affected than others in a genotype-dependent manner. Biochemical analyses of ROCK substrates in synaptic fractions revealed that phosphorylation of LIM kinase and cofilin were reduced in ROCK1+/− and ROCK2+/− mice, while phosphorylation of myosin light chain was decreased exclusively in ROCK1+/− mice. Collectively, these observations implicate ROCK1 as a novel regulatory factor of neuronal dendritic structure and detail distinct and complementary roles of ROCKs in mPFC dendritic spine structure.
KeywordsRho kinase LIM kinase Dendritic spines Prefrontal cortex Dendritic arbor Morphometry Synaptosomes
This work was supported by the National Institutes of Health through NIA AG061800 to J.H.H., NIA AG054719 to J.H.H., and NIA AG043552 to J.H.H. Additional support stemmed from a New Investigator Research Grant 2015-NIRG-339422 to J.H.H. from the Alzheimer’s Association.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. This article does not contain any studies with human participants performed by any of the authors.
- Anderson RM, Birnie AK, Koblesky NK, Romig-Martin SA, Radley JJ (2014) Adrenocortical status predicts the degree of age-related deficits in prefrontal structural plasticity and working memory. J Neurosci 34:8387–8397. https://doi.org/10.1523/JNEUROSCI.1385-14.2014 CrossRefPubMedPubMedCentralGoogle Scholar
- Chan CC, Khodarahmi K, Liu J, Sutherland D, Oschipok LW, Steeves JD, Tetzlaff W (2005) Dose-dependent beneficial and detrimental effects of ROCK inhibitor Y27632 on axonal sprouting and functional recovery after rat spinal cord injury. Exp Neurol 196:352–364 https://doi.org/10.1016/j.expneurol.2005.08.011 CrossRefPubMedGoogle Scholar
- Douglas RJ, Martin KA (2004) Neuronal circuits of the neocortex. Annu Rev Neurosci 27:419–451. https://doi.org/10.1146/annurev.neuro.27.070203.144152 CrossRefPubMedGoogle Scholar
- Duffy P, Schmandke A, Sigworth J, Narumiya S, Cafferty WB, Strittmatter SM (2009) Rho-associated kinase II (ROCKII) limits axonal growth after trauma within the adult mouse spinal cord. J Neurosci 29:15266–15276. https://doi.org/10.1523/JNEUROSCI.4650-09.2009 CrossRefPubMedPubMedCentralGoogle Scholar
- Feng Y, LoGrasso PV, Defert O, Li R (2015) Rho kinase (ROCK) inhibitors and their therapeutic potential. J Med Chem 59:2269–2300Google Scholar
- Gentry EG, Henderson BW, Arrant AE, Gearing M, Feng Y, Riddle NC, Herskowitz JH (2016) Rho kinase inhibition as a therapeutic for progressive supranuclear palsy and corticobasal degeneration. J Neurosci 36:1316–1323. https://doi.org/10.1523/JNEUROSCI.2336-15.2016 CrossRefPubMedPubMedCentralGoogle Scholar
- Lapchak PA, Han MK (2010) Simvastatin improves clinical scores in a rabbit multiple infarct ischemic stroke model: synergism with a ROCK inhibitor but not the thrombolytic tissue plasminogen activator. Brain Res 1344:217–225. https://doi.org/10.1016/j.brainres.2010.05.035 CrossRefPubMedPubMedCentralGoogle Scholar
- Radley JJ et al (2004) Chronic behavioral stress induces apical dendritic reorganization in pyramidal neurons of the medial prefrontal cortex. Neuroscience 125:1–6. https://doi.org/10.1016/j.neuroscience.2004.01.006 CrossRefPubMedGoogle Scholar
- Radley JJ, Anderson RM, Cosme CV, Glanz RM, Miller MC, Romig-Martin SA, LaLumiere RT (2015) The contingency of cocaine administration accounts for structural and functional medial prefrontal deficits and increased adrenocortical. Activ J Neurosci 35:11897–11910. https://doi.org/10.1523/JNEUROSCI.4961-14.2015 CrossRefGoogle Scholar
- Rikitake Y et al (2005) Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection. Stroke 36:2251–2257. https://doi.org/10.1161/01.STR.0000181077.84981.11 CrossRefPubMedPubMedCentralGoogle Scholar